insights_auto
Why is ARWR up 3.31%?
Dive Deeperchevron_right
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$62.75
arrow_upward
+3.31%(+2.01) 1D
Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$60.72
High
$62.99
Low
$60.44
Mkt. cap
8.86B
Avg. vol.
2.08M
Volume
0.00
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
Open
$60.72
High
$62.99
Low
$60.44
Mkt. cap
8.86B
Avg. vol.
2.08M
Volume
0.00
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Simply Wall Street
·
2 hours ago
Arrowhead Pharmaceuticals (ARWR) Climbed Today, What Is Behind The Move?
Stock Traders Daily
·
1 day ago
(ARWR) Risk Channels and Responsive Allocation
TipRanks
·
2 days ago
Arrowhead’s Plozasiran Trial Completion Signals a Pivotal Moment for ARWR Investors
www.dars.gov.et
·
3 months ago
ARWR Q2 2026 Earnings: EPS Surprise Beats Estimates as Clinical Progress Continues - Earnings Risk Report
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com